Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Mylan Inc    

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2016 11 021 M
EBIT 2016 3 195 M
Net income 2016 1 054 M
Debt 2016 11 500 M
Yield 2016 -
Sales 2017 12 772 M
EBIT 2017 3 820 M
Net income 2017 2 263 M
Debt 2017 11 101 M
Yield 2017 -
P/E ratio 2016 19,21
P/E ratio 2017 9,81
EV / Sales2016 2,78x
EV / Sales2017 2,37x
Capitalization 19 189 M
More Financials
Company
Mylan N.V., is a pharmaceutical company which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceutical products.It operates through two segments: Generic and Specialty.The Generic pharmaceutical business is conducted primarily in the U.S. and... 
Sector
Pharmaceuticals
Calendar
03/02Earnings Release
More about the company
Surperformance© ratings of Mylan Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on MYLAN INC
12/07 MYLAN : EpiPen maker Mylan to restructure, cut workforce
12/07 MYLAN N.V. (NASDAQ : MYL) Files An 8-K Costs Associated with Exit or Disposal Ac..
12/07 MYLAN N.V. : Costs Associated with Exit or Disposal Activities (form 8-K)
12/07 MYLAN : seeking to reduce workforce
12/05 MYLAN : Rosen Law Firm Reminds Mylan N.V. Investors of Important Dec. 12 Deadlin..
12/02 MYLAN NV : DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors..
12/02 Pharma execs weigh in on possible changes under Trump
12/01 MYLAN : The Law Offices of Howard G. Smith Announces the Filing of a Securities ..
12/01 MYLAN : Commitment to Stemming the Tide of HIV/AIDS as Strong as Ever
11/29 MYLAN : Signs Sub-license Agreement with the Medicines Patent Pool to Increase A..
More news
Sector news : Pharmaceuticals - NEC
12/07 MYLAN : EpiPen maker Mylan to restructure, cut workforce
12/07DJABBOTT LABORATORIES : Seeks to Terminate Alere Deal -- Update
12/07DJPFIZER : Fined $107 Million for Overcharging U.K. for Epilepsy Drug
12/07DJABBOTT LABORATORIES : Seeks to Terminate Alere Deal
12/07DJMARKET SNAPSHOT : Dow, S&P 500 Set Intraday Records, But Health-care Slumps On T..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
2015 Mylan (MYL) Heather M. Bresch on Q4 2014 Results - Earnings Call Transcript
2015 Mylan Q4 revenues up 15%, Specialty up 38%
2015 Mylan (MYL) Q4 2014 Results - Earnings Call Webcast
2015 Mylan EPS in-line, beats on revenue
2015 Notable earnings after Monday?s close
Advertisement
Chart MYLAN INC
Duration : Period :
Mylan Inc Technical Analysis Chart | US6285301072 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 50,9 $
Spread / Average Target 42%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Heather M. Bresch Chief Executive Officer & Executive Director
Rajiv Malik President & Executive Director
Robert J. Coury Executive Chairman
Kenneth Scott Parks Chief Financial Officer
Wendy Cameron Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MYLAN INC-1.66%19 189
JOHNSON & JOHNSON9.09%304 863
PFIZER INC.-2.23%191 517
ROCHE HOLDING LTD.-19.65%190 397
NOVARTIS AG-20.79%180 387
MERCK & CO., INC.14.12%166 200
More Results